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Langerhans cells are the antigen-presenting cells of the 
skin, belonging to the family of dendritic cells, which 
present exogenous antigens in the context of major 
histocompatibility complex class II (MHC-I1) mole-
cules to CD4+ T lymphocytes. Langerhans cells are po-
tent stimulators of different T-cell responses including 
primary immune responses. Culturing of Langerhans 
cells leads to modulation of their phenotype and func-
tion, as they seem more capable of activating T cells, 
whereas freshly isolated Langerhans cells are special-
ized in the endocytosing and processing of antigen. We 
studied the intracellular distribution ofMHC-I1 mole-
cules and invariant chain (I-chain) in resident Langer-
hans cells using immunogold labeling of ultrathin 
cryosections of human epidermis and found the ma-
jority of intracellular MHC-I1 molecules present on 
membranes of rough endoplasmic reticulum and in 
so-called MHC-I1-enriched compartments (MIIC). 
C ells expressing major histocompatibility complex class.!1 (MHC-II) molecules are involved in the pre-sentation of exogenous antigens to T cells. The anti-gen-presenting cells endocytose or phagocytose and proteolytically degrade antigens to presentable pep-
tides. MHC-II molecules consist of an a- and p-chain, which are 
assembled in the endoplasmic reticulum [1], where they associate 
with a third membrane protein, the invariant chain or I-chain [2]. 
The I-chain is thought to prevent premature binding of endogenous 
peptides present in the endoplasmic reticulum or Golgi complex to 
ap-dimers [3,4]. Moreover, a sorting signal in the cytoplasmic tail of 
I-chain is implicated in the selective transport of newly synthesized 
ap/I-chain trimers from the Golgi complex to endocytotic com-
partments [5 - 7]. A minor fraction seems to escape this pathway and 
is transported directly to the plasma membrane [8]. After arrival of 
the MHC-II/I-chain complexes in endocytotic compartments, the 
I-chain is rapidly degraded by acid proteases, thereby enabling pep-
tides derived from internalized antigen to bind to MHC-II mole-
cules [9]. The peptide-loaded MHC-II molecules are then trans-
ported to the cell surface for presentation of peptide to CD4+ T 
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The MIIC appeared to be negative for the cation-inde-
pendent mannose 6-phosphate receptor and positive 
for the lysosomal enzyme p-hexosaminidase and ac-
quired the endocytotic tracer, cationized horseradish 
peroxidase, only after 60 min of internalization. 
Taken together, these data show that MIIC in Langer-
hans cells share characteristics with lysosomes. I-chain, 
which is associated with MHC-I1 molecules in early 
biosynthetic compartments, was found in the rough 
endoplasmic reticulum and Golgi complex, but was 
detected only occasionally in MIIC and at the plasma 
membrane. MIIC with internal membrane vesicles 
showed some I-chain labeling, suggesting that these 
are newly formed MIIC in which degradation of the 
I-chain is not yet complete. Key words: dendritic celli 
electron microscopyl immunogold labelingl MHC class II. 
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lymphocytes involved in both cellular and humoral immune re-
sponses. 
Antigen-presenting cells expressing MHC-II include B lympho-
cytes, macrophages, and dendritic cells. The latter are found in 
many lymphoid- and nonlymphoid tissues and represent a distinct 
lineage of antigen-presenting cells, specialized to initiate primary 
T-cell responses [10-12] . Langerhans cells are the dendritic cells of 
the epidermis. Morphologically they can easily be recognized by 
their lobulated nucleus and long cytoplasmic processes, extending 
between the epidermal cells. Langerhans cells contain a characteris-
tic cytoplasmic compartment, the Birbeck granule, appearing as a 
rod-shaped organelle with a zipper-like striation [13]. The function 
of Birbeck granules is still unknown, but it has been proposed that 
the granules are involved in endocytosis [14,15] or playa role in 
antigen processing [16] . 
Langerhans cells are involved in antigen-specific T-cell activa-
tion and cytotoxic T-cell proliferation, and act as stimulator cells in 
autologous and allogenic mixed leukocyte reactions [17,18]. In 
contrast to cultured Langerhans cells, freshly isolated ones are capa-
ble of processing and presenting intact protein [19]. Because of 
markedly increased expression of MHC-II molecules and adhesion 
molecules, cultured Langerhans cells have acquired an enhanced 
immunostimulatory capacity and the unique potential to induce 
primary T-cell responses [20]. This phenotypic change of cultured 
Langerhans cells [21,22], as well as their resemblance to lymphoid 
dendritic cells, has led to the hypothesis that resident Langerhans 
cells can pick up and process antigen and then travel to the draining 
lymph node for presentation of antigenic peptide. 
The intracellular distribution of MHC-II molecules has been ex-
tensively studied in B cells and macrophages. In both cell types the 
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majority of the intracellular MHC-I1 molecules is found in vesicular 
structures, the so-called MHC-II compartments (MIIC), which 
share characteristics with Iysosomes [23,24]. In B cells, these com-
partments have a multilaminar appearance and contain the lysoso-
mal enzyme fi-hexosaminidase and lysosomal membrane proteins. 
In addition, they lack the cation-dependent and cation-independent 
mannose 6-phosphate receptors (CD-MPR, CI-MPR), features in 
common with Iysosomes [25,26]. Furthermore, in both B cells and 
macrophages, MIIC are positioned late in the endocytotic route 
[23,24]. Our recent studies on macrophages have shown that pep-
tide loading of MHC-I1 molecules occurs in MIlC and that MIIC 
membranes are capable of specifically stimulating T cells [27,28]. 
We have now investigated for the first time the precise intracellular 
distribution ofMHC-1I molecules and ofI-chain in human Langer-
hans cells, using immunogold labeling on ultrathin cryosections 
[29]. We show that Langerhans cells contain typical MIIC, which 
harbor most of the intracellular MHC-I1. The MIIC contained only 
a minor fraction of the intracellular I-chain labeling. Compared to B 
cells, a relatively high fraction of MHC-II molecules was found in 
membranes of the rough endoplasmic reticulum, whereas only a 
small percentage of the total MHC-I1 was detected on the cell 
surface. These results suggest that resident Langerhans cells are 
actively synthesizing MHC-I1 molecules, which accumulate in 
MIle. 
MATERIALS AND METHODS 
Tissue Preparation Skin was obtained from breasts of healthy individuals 
undergoing plastic surgery. Small tissue blocks consisting of epidermis and 
dermis were fixed in a mixture of 2% paraformaldehyde and 1 % acrolein for 
24 h, or in 0.5% glutaraldehyde and 1 % acrolein for 2 h in 0.1 M phosphate 
buffer (pH 7.4) at room temperature. Processing for ultrathin cryosectioning 
was performed according to the Tokuyasu method, as adapted by Slot et al 
[29]. Briefly, after fixation, tissue blocks were washed twice in phosphate-
buffered saline (PBS) and twice in PBS with 0.15 M glycine. Blocks of 
1 mm3 were embedded in 10% gelatin, infiltrated with 2.3 M sucrose at 
room temperature, and frozen in liquid nitrogen. 
Labeling Procedure and Antibodies Ultrathin cryosections were sin-
gle or double immunolabeled with 10 nm or 10 and 15 nm gold, respec-
tively, as described [30] . The sections were contrasted with 2% uranyl-oxa-
late at pH 7 and embedded in 2% methylcellulose containing 0.5% uranyl 
acetate. Background label as revealed without use of antibodies or with an 
irrelevant control serum was negligible. 
Rabbit antibodies against the following proteins were used: class II a-
chain [31], I-chain (cytoplasmic tail) (kindly provided by Dr Ph. Morton, 
Monsanto Company, Chesterfield, MO), I-chain (luminal epitope) [32] 
(kindly provided by Dr. J. Pieters, Department of Cellular Biochemistry, 
The Netherlands Cancer Institute, Amsterdam, The Netherlands), p-hexo-
saminidase, CI-MPR [33], and horseradish peroxidase (HRP) (Sigma, 
P7899). 
Quantitation ofImmunogold To evaluate the intracellular distribution 
of MHC-I1 molecules and I-chain sel11iquantitatively, immunogold particles 
forthe a-chain of MHC-I1 or for the cytoplasmic epitope of the I-chain were 
counted in single-labeled sections. From epidermal sections, 20 cells were 
randomly selected at a magnification of 1200X, and gold particles were 
counted directly in the microscope at an instrumental magnification of 
15,000X. Background label was determined by using a rabbit antibody 
against rat amylase and was subtracted from the MHC-II and I-chain gold for 
each compartment (see Table I). 
Uptake of Cationized HRP (cHRP) Preliminary experiments with the 
endocytotic markers HRP and 5 nm bovine serum albumin (BSA)-gold 
showed that the uptake of these markers by Langerhans cells in small tissue 
blocks was extremely low. By making the HRP (Sigma, type VI) cationic, 
the uptake efficiency was strongly improved, probably by binding to nega-
tively charged sur£Ke proteins in the membrane. cHRP was made according 
to Rennke et at [34] (kindly provided by Dr. W. Stoorvogel, Department of 
Cell Biology, Utrecht University, The Netherlands), and small tissue blocks 
were incubated in Eagle's Minimal Essential Medium (MEM) containing 
0.75 mg/ml cHRP at 37 °C in a 5% CO2 atmosphere. Continuous uptake 
for 10, 30, and 60 min was stopped by adding excess ice-cold medium 
without cHRP. After being washed scveral times, tissue blocks were fixed 
and prepared as described above. The immunolabeling procedure was as 
above, except that a 15-min incubation in 1 % glutaraldehyde was introduced 
before the first labeling step to firmly crosslink the cHRP to the cryosection. 
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Table I. Percentages of Immunogold Labeling for 
MHC-II and I-Chain in Different Cell Comparttnents 
of Langerhans Cells' 
Endoplasmic reticulum 
Golgi complex 
Endosomcs 
MIlC 
Vesicles 
Plasma Membrane 
Bubeck granules 
MHC-II 
26.9 
3.0 
3.5 
44.2 
10.2 
11.1 
1.1 
I-Chain 
68.9 
7.8 
0.5 
5.2 
15.4 
1.8 
0.4 
• The number of gold particles on each compamnent was expressed as a percentage of 
the total number of gold particles counted in 20 cell profiles. 
RESULTS 
With the electron microscope Langerhans cells could easily be 
identified by their cytoplasmic processes, electron-lucent cyto-
plasm, presence of Birbeck granules, and lack of desmosomes. The 
cells contained large Golgi complexes and numerous vesicular 
structures with internal membrane sheets or internal vesicles or 
with electron-dense content and endosome-like structures with oc-
casional internal vesicles. 
Localization of MHC-II Immullogold labeling for MHC-I1 
was found on membranes of the rough endoplasmic reticulum, 
Golgi complex (Fig la), and the compartments with dense content 
and either internal vesicles or membrane sheets (Figs la,b) . Because 
of their morphology and enrichment of MHC-I1 and the criteria 
described below, we call these compartments MHC-II compart-
ments (MIle), according to our previous definition of MIle in B 
cells [23]. The presence of MHC-I1 molecules in the rough endo-
plasmic reticulum is demonstrated in Fig 3b, showing part of the 
nuclear envelope containing MHC-II labeling. The cell surface, 
endosome-like structures, and Birbeck granules were only slightly 
positive for MHC-I1. Furthermore, we found numerous small vesi-
cles positive for MHC-II, which were concentrated in the Golgi 
area (Fig la) or occurred close to MIle. The nature of these vesicles 
is unclear but their close association with the trans-Golgi face sug-
gests that they may represent post-Golgi-forming stages of MIle. 
The fact that these vesicles also contained I-chain labeling supports 
this idea (see below). To determine the possible relation of the MIIC 
to the endocytotic pathway, we studied the internalization of an 
endocytotic tracer. 
Internalization of cHRP We preferred to use small tissue 
blocks for our internalization experiments, consisting of intact epi-
dermis and dermis, instead of using isolated Langerhans cells, with 
possibly damaged morphology. When these blocks were incubated 
with BSA-gold particles as the endocytotic tracer, Langerhans cells 
were hardly labeled due to the insufficient penetration of the epi-
dermis by the tracer. We therefore used cHRP, which entered the 
epidermal layer much better. After 10, 30 and 60 min of continuous 
uptake at 37°C, tissue blocks were fixed and processed as described . 
After 10 min of uptake we found cHRP mainly in Birbeck granules, 
especially in their dilated terminal parts (Fig 2a) and in sma.ll endo-
cytotic, MHC-II-negative vesicles close to the plasma membrane 
(not shown). After 30 min, cHRP was also detected in typical endo-
somes with few internal vesicles that occasionally showed some 
MHC-Il labeling (Fig 2b). Only after 60 min of incubation were 
the MIlC labeled for cHRP (Fig 2c). Thus the MIIC in Langerhans 
cells are situated late in the endocytotic pathway. The small MHC-
II - positive vesicles on the trans-side of the Golgi complex re-
mained negative for cHRP during all incubation times. 
Further Characterization of MIIC The nature of the MIlC 
was further investigated by immunolabeling for markers that allow 
discrimination between endosomes and Iysosomes. The lysosomal 
enzyme fi-hexosaminidase was seen to be prominently present in 
MIIC (Fig 3a). The CI-MPR. which is associated with endosomes 
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Figure 1. Ultrathin cryosections of resident Langerhans cells labeled for MHC-II molecules. a) MHC-Illabeling (10 nm gold particles) is present in 
the Golgi complex (GC) and with associated vesicles (V) at its trans side, in a dense MIlC (star) and in Birbeck granules (BG). b) Two MIlC (stars) with internal 
membrane sheets are shown, containing abundant labeling for MHC-Il. BG, Birbeck granule. Bars, 100 nm. 
and absent from lysosomes [28,33,35], was not detected in MIIC, 
whereas it was present abundantly in endosomes (Fig 3b) . This is 
consistent with the idea of MIIC being lysosome-like structures. 
Because the MIIC in Langerhans cells consisted of several morpho-
logic subclasses (containing internal vesicles, membrane sheets, or 
dense material), suggesting the existence of different stages of 
MIIC, it was of interest to study the localization of the I-chain. The 
I-chain is associated with MHC-II molecules during the earlier 
steps in the biosynthetic route, but is degraded shortly after exiting 
the Golgi complex [9,36]. We therefore considered the presence 
of I-chain as an indication of a biosynthetic compartment of 
MHC-II. 
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Figure 2. Uptake of cHRP. Tissue blocks consisting of epidermis and dermis were incubated with cHRP for 10, 30, and 60 min, and ultrathin cryosections 
were either single immunolabeled for cHRP (10 nm gold particles) or double ill1lllunolabeled for cHRP (15 nlll gold particles) and MHC-II molecules (10 nm 
gold particles). a) After 10 min of internalization, cHRP is present in a Birbeck granule (BG), especially in its dilated terminal portion. PM, plasma membrane . . 
After 30 min (b), an endosome (E) with a few internal vesicles contains cHRP as well as some MHC-lliabeling. The MIlC (star) has not yet been reached by 
the cHRP. MIIC positive for cHRP (stars) are found only after 60 min of uptake (c). BG, Birbeck granules. Bars, 100 lUn. 
Localization of the I-Chain For the immunolocalization of the 
I-chain we used two different antibodies, one against a luminal 
epitope and one against the cytoplasmic taiL Both antibodies 
showed a very high expression of the I-chain in the rough endoplas-
mic reticulum, including the nuclear envelope (Fig 4a), and in the 
Golgi cisternae (Fig 4b,c), whereas labeling in MIle was less (Fig 
4c). It should be noted that I-chain expression varied between cells. 
Primarily, MIle with internal vesicles and lucent content were 
labeled with the antibody against the cytoplasmic tail (Fig 4a,c). 
This suggests that other types of MIle with membrane sheets and 
dense content were positioned later ill the biosynthetic route of 
MIle. We seldom observed I-chain labeling on the plasma mem-
brane, and Birbeck granules were negative with both antibodies. 
Quantitation of MHC-I1 and I-Chain Distribution To ob-
tain a semiquantitative impression of the distributions of MHC-II 
and the I-chain, ultrathin cryosections were immunolabeled either 
with MHC-I1 or I-chain antibody, and the respective immunogold 
particles were counted on randomly selected Langerhans cell pro-
files as described in Materials and Methods. Gold labeling of the fol-
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Figure 3. Further characterization ofMIIC. Ultrathin cryosections were double labe led for either marker protein fJ-h exosaminidase or C I-MPR (15 nm 
gold particles) and MHC-Il (10 nm gold pa.rticles). The lysosomal enzyme p-hexosaminidasc (fJ-HEX) shows clear colocalization with MHC-U in MIlC 
(stars) (a) . Especially the smaller MIIC show less fJ-h exosaminidase. In (b) endosomes (E) are labeled for C I-MPR, whereas this receptor is absent from MIIC 
(stars). Note that the nuclear envelope (NE) is labeled for MHC-Il. BG, Birbeck granules. Bars, 100 nm. 
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Figure 4. Localization ofI-chain. Ultrathin cryosections were labeled for the I-chain using two an tibodies, one recognizing a luminal epitope (I-ch L, 15 
nm gold particles) and the other the cytoplasmic tail (I-ch T, 10 nm gold particles). Double-labeling with these antibod ies (a) shows that both epitopes of the 
I-chain are abundantly expressed in the endoplasmic reticulum, including the nuclear envelope (NE). The Arrowhead points to a MIlC with internal vesicles 
labeled only for the cytoplasmic tail of the I-chain. BG, Birbeck granules. (b) Luminal epitope of the I-chain (15 nm gold particles) and MHC-II (10 nm gold 
particles) are present in several cisternae of the Golgi complex (GC), whereas the I-chain cannot be detected in the MrIC (slnr). However, w hen a 
double-labeling is performed for the cytoplasmic tail of the I-chain (15 nm gold particles) and MHC-JI (10 nm gold particles) (c), the MIIC (slar) does show 
I-chain labeling. Bars, 100 nm. 
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lowing cell compartments was quantified: rough endoplasmic retic-
ulum, Golgi complex, Birbeck granules, endosomes, MIlC, Golgi 
and MIlC-associated vesicles, and plasma membrane (Table I). Tis-
sue samples of two individuals were counted, but because the data 
obtained were very similar, only the results of one individual are 
shown in Table I. MIIC contained the highest percentage of 
MHC-I1 labeling, namely 44.2% of the total labeling. The rough . 
endoplasmic reticulum represented the second most important in-
tracellular compartment for MHC-Il labeling, containing 26.9%. 
On the plasma membrane 11.1 % was present; 3.0% was in the 
Golgi complex, and 3.5% in the endosomes. The Golgi and MIlC-
associated vesicles (Fig la) contained 10.2% of the total labeling. 
Birbeck granules contained only 1.1 %. 
Quantitation of I-chain distribution was performed as described 
for MHC-Il, using the anti-tail antibody, as it showed more intense 
labeling than the antibody against the luminal epitope (Fig 4a). As 
shown in Table I, the rough endoplasmic reticulum contained most 
of the labeling (68 .9%), whereas MIIC contained only 5.2% of the 
total amount oflabeling. As mentioned above, especially MIlC with 
internal vesicles showed I-chain label. I-chain labeling over the 
Golgi complex and vesicles associated with the Golgi and MIlC 
amounted to 7.8% and 15.4%, respectively. This strongly suggests 
that the latter vesicles are part of the biosynthetic route of MHC-lI 
and may be involved in the transport of ap/I-chain complexes to 
the endocytotic compartments, including MIlC. 
DISCUSSION 
In this study we describe the subcellular distribution of MHC-Il 
molecules and I-chain in human resident Langerhans cells, to iden-
tify the organelles in this potent antigen-presenting cell type that 
may be involved in antigen processing and MHC-Il loading. About 
half of the cell's MHC-I1 labeling was found intracellularly, espe-
cially in the MIle. Other immunoelectron microscopy studies on 
human Langerhans cells and dendritic cells have also demonstrated 
high MHC-I1 labeling intracellularly [37,38]. Like MIIC in human 
B cells [23] and mouse macrophages [24], MIlC in Langerhans cells 
share characteristics with lysosomes: they lack CI-MPR, show 
strong labeling for the lysosomal enzyme p-hexosaminidase, and are 
positioned late in the endocytotic route. In a recent study on macro-
phages it was shown that MIIC represent the compartment in 
which MHC-I1 molecules are loaded with peptide [30]. Peptides are 
bound to newly synthesized MHC-Il molecules [31,39]' and as 
compared to other plasma membrane proteins, newly synthesized 
MHC-Il molecules are strongly delayed before appearing at the cell 
surface [31]. This, and the high density of MHC-Il molecules in 
MIlC, suggests that MIIC represent waiting rooms for newly syn-
thesized MHC-Il molecules for binding with peptide. The MIlC in 
macrophages [24], B-cells [23], and Langerhans cells (present study) 
are late endocytotic compartments, suggesting that exogenous anti-
gens can reach the MIlC only after traversing most of the endocyto-
tic route. The high intracellular expression of MHC-lI, together 
with the processing and loading function of MIIC, are compatible 
with the idea that epidermal Langerhans cells are fully equipped for 
antigen processing. Langerhans cells have the unique potential to 
retain antigen in immunogenic form for at least 2 d [40], which is 
much longer than in antigen-pulsed B cells. This may be related to 
the time required for Langerhans cells to migrate from the epider-
mis to the draining lymphoid tissue for presentation of the antigen 
to T cells [41] . 
Our semiquantitative data on the MHC-Il distribution suggest 
similarity between the resident epidermal Langerhans cells and 
freshly isolated Langerhans cells. First, the cell surface expression of 
MHC-I1 on the epidermal Langerhans cells is relatively low, just as 
in freshly isolated Langerhans cells [42,43]' Second, biochemical 
studies have shown that MHC-I1 synthesis is very high in freshly 
isolated Langerhans cells [38,44], which fits with our finding that 
the rough endoplasmic reticulum contains almost one-third of the 
total MHC-II labeling. The low surface expression of MHC-II on 
resident epidermal Langerhans cells suggests that they are not yet 
actively presenting antigen, but rather are active in producing 
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MHC-II, waltlllg for the event that antigen is internalized and 
processed. When freshly isolated Langerbans cells are cultured, 
MHC-Il synthesis decreases [45], whereas the expression at the cell 
surface is strongly enhanced. This suggests that the MHC-I1 mole-
cules present in rough endoplasmic reticulum and MIIC of the 
resident Langerhans cells are transported to the plasma membrane 
when the Langerhans cells have left the epidermis. 
Typical endosomes in Langerhans cells were electron-lucent 
structures, sometimes with a few internal vesicles. They were im-
munolabeled for CI-MPR and contained internalized cHRP after 
30 min of uptake. The small numbers of MHC-II (3.5% of total 
label) in these structures probably reflect endocytosed MHC-Il 
molecules [8,46,47]' That these endosomal MHC-I1 molecules are 
derived from the biosynthetic pathway, i.e., the Golgi complex, can 
not be ruled out. Furthermore, the endosomal MHC-II molecules 
either can be on their way to being degraded or belong to a small 
pool that is involved in recycling [48]. The fact that we seldom 
detected colocalization of MHC-II with cHRP after 10 min of up-
take suggests that only a very small number of the MHC-I1 mole-
cules is being internalized. 
We found small vesicles containing approximately 10% of the 
total cellular MHC-II labeling at the trans-face of the Golgi com-
plex. The internalization experiments with cHRP showed that 
these vesicles are probably not endocytotic in nature. The fact that 
they also contain a considerable fraction ofI-chain labeling (15.4%) 
indicates that these vesicles are part of the biosynthetic pathway of 
MHC-I1, involved in delivery of MHC-I1 molecules to MIle. The 
vesicles were not CI-MPR labeled and did not show a cytoplasmic 
coat, suggesting that they are different from the vesicles carrying 
newly synthesized lysosomal enzymes to Iysosomes [25,33]' MIIC 
contained only a minor fraction of the total I-chain labeling (5.2%), 
which probably reflects the rapid I-chain degradation after Golgi 
passage [9,36]' The antibody against the cytoplasmic tai l of the 
I-chain did show some label in MIIC, mostly in those with internal 
vesicles. This suggests that this type of MIle represents an early 
stage of MIlC that has just received Golgi-derived MHC-I1 mole-
cules and in which degradation of the I-chain is not yet complete. In 
the human melanoma cell line MelJuSo, the I-chain has been found 
in three distinct endosomal compartments [32]: early endosomes, 
multi-vesicular bodies, and prelysosomes. The rate of proteolysis in 
different cell types could account for the different fractions of 1-
chain present in MIle. The epidermal Langerhans cells express very 
little I-chain molecules on the plasma membrane or in early endo-
cytotic structures, indicating that transport of MHC-Il/I-chain 
complexes to the cell surface and subsequent internalization are 
minor events [8] . In some cases the I-chain has been detected on the 
surface of B cells [8,46] and on freshly isolated mouse Langerhans 
cells [40,44]' but whether this I-chain had reached the surface to-
gether with MHC-I1 or results from the mis-sorting of the free 
I-chain is unknown. 
Our internalization experiments with cHRP showed that Bir-
beck granules represent early endocytotic structures. Presently, the 
function ofBirbeck granules is unknown, although a possible role in 
endocytosis has been proposed. Birbeck granules have been found to 
fuse with lysosomal structures [14,15]' indicating that they might 
deliver exogenous material to the "conventional" endocytotic 
route. However, we only once observed a Birbeck granule attached 
to a dense structure positive for MHC-I1 indicating that if fusion can 
occur between these structures, this is either a very rapid or a rare 
event. Others suggest that Birbeck granules might be derived from 
endosomes, representing a tubular portion of these compartments 
with a unique morphology [16]. 
In conclusion, in human Langerhans cells the majority of the 
intracellular MHC-II molecules was present ill MIIC, which share 
characteristics with Iysosomes. I-chain was mainly located in the 
rough endoplasmic reticulum and Golgi complex, Golgi and MIIC-
associated vesicles, and in occasional MIlC, which were character-
ized by the presence of internal vesicles rather than membrane 
sheets. Given that newly synthesized ap/I-chain complexes after 
Golgi passage are delivered to endocytotic structures, we propose 
VOL. 103, NO. 4 OCTOBER 1994 
that MIlC with internal vesicles are reCipients of Golgi-derived 
MHC-II molecules. Finally, our Langerhans cells displayed a phe-
notype similar to that of freshly isolated Langerhans cells, i.e., with 
a high percentage of MHC-II molecules in the rough endoplasmic 
reticulum and a relatively small amount at the plasma membrane. 
This project was slIpported by gralll 900-523-094 ofNWO. 
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